NCT02351024View on ClinicalTrials.gov

Phase I Study PK Study With OXP005 and Naprosyn

PHASE1CompletedINTERVENTIONAL
Timeline

Start Date

February 28, 2015

Primary Completion Date

March 31, 2015

Study Completion Date

March 31, 2015

Conditions
Pharmacokinetics
Interventions
DRUG

OXP005

DRUG

Naprosyn®

Trial Locations (1)

Unknown

Quotient Clinical Ltd, Nottingham

Sponsors
All Listed Sponsors
lead

Oxford Pharmascience Ltd

INDUSTRY

NCT02351024 - Phase I Study PK Study With OXP005 and Naprosyn | Biotech Hunter | Biotech Hunter